Related Experiment Video
Updated: Jun 27, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Recent Advances in Natural Products for Colitis: Mechanisms and Translational Perspectives
Fulin Jin1, Yaning Shi1, Lijun Wang1
1College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.
Veterinary Sciences
|June 26, 2026
Summary
Natural products show promise for treating colitis by targeting inflammation and gut imbalance. Further research is needed to validate their efficacy and safety for clinical use in both human and veterinary medicine.
Area of Science:
- Gastroenterology
- Pharmacology
- Natural Products Chemistry
Background:
- Colitis is a chronic inflammatory disorder with limitations in current treatments.
- Natural products offer diverse bioactivity and multitarget potential for colitis intervention.
- Colitis impacts animal health and incurs significant treatment costs, highlighting the need for novel strategies.
Purpose of the Study:
- To review natural products investigated for colitis treatment.
- To discuss their mechanisms of action and therapeutic potential.
- To identify research gaps and future directions for natural product-based colitis therapies.
Main Methods:
- Literature review of natural products for colitis.
- Categorization of natural products (flavonoids, polyphenols, alkaloids, etc.).
- Analysis of mechanisms including anti-inflammatory, antioxidant, and microbiota modulation.
Main Results:
- Various natural product classes exhibit anti-inflammatory and gut-protective effects.
- Mechanisms involve reducing oxidative stress, restoring barrier function, and modulating immune responses.
- Research limitations include reliance on preclinical models and insufficient clinical evidence.
Conclusions:
- Natural products are a valuable source for colitis therapeutics.
- Clinical translation requires rigorous mechanistic studies, standardization, and clinical trials.
- Future research should focus on target validation, bioavailability, and causality in microbiota interactions.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...